Company Filing History:
Years Active: 2023-2024
Title: Mette Uhre Anby: Innovator in Pharmaceutical Compositions
Introduction
Mette Uhre Anby is a notable inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target ryanodine receptors. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Mette's latest patents focus on pharmaceutical compositions that comprise a ryanodine receptor modulator. One of her key inventions is a modified-release pharmaceutical composition that includes 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, along with a pharmaceutically-acceptable excipient. This innovative composition is designed to treat various conditions associated with ryanodine receptors, including cardiac disorders, musculoskeletal diseases, cancer-related muscle weakness, malignant hyperthermia, and diabetes.
Career Highlights
Mette Uhre Anby is currently associated with Armgo Pharma, Inc., where she continues to develop her groundbreaking work in pharmaceuticals. Her expertise in the field has led to significant advancements in the treatment of complex medical conditions.
Collaborations
Mette has collaborated with esteemed colleagues such as Eugene E Marcantonio and Jérôme Binet. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Mette Uhre Anby is a pioneering inventor whose work in pharmaceutical compositions is making a substantial impact on medical treatments. Her innovative approaches and collaborations are setting new standards in the industry.